Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STOML2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | KCNH5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PCDHA8 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | STRN4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DHX16 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | MLIP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | OR2A42 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RHBDL3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CSNK2A2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ROPN1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |